TC
DRTS icon

Telemus Capital’s Alpha Tau Medical DRTS Stock Holding History

Telemus Capital’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$89.4K Buy
+29,716
New +$95.7K 0.01% 322

Other funds holding DRTS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
SAM
Satovsky Asset Management New York $566M AUM 15.8% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemus Capital's DRTS Position: Q4 2023 in Review

Telemus Capital opened a new position in Alpha Tau Medical (DRTS) in Q4 2023: 29,716 shares worth $89.4K. The stake represents 0.01% of the portfolio and ranks #322 among its holdings.

26 funds tracked by Wall St. Rank hold DRTS as of Q4 2023.

  • Telemus Capital held 29,716 shares of Alpha Tau Medical worth $89.4K as of Q4 2023.
  • Alpha Tau Medical was a new Telemus Capital position in Q4 2023.
  • Alpha Tau Medical made up 0.01% of Telemus Capital's portfolio in Q4 2023, its #322 holding.
  • 26 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q4 2023.

Based on Telemus Capital's 13F filing for Q4 2023, filed 1 Feb 2024.